Noticeably, as suggested in our study, CXCL1, TLR6 and OSM have been documented to be targeted genes of DNA methylated modification in other diseases, such as schizophrenia [28], type 1 diabetes [29] and Richter syndrome [30]. The gene discussed is OSM; the disease is Richter syndrome.